Driota Pharma Private Limited - Company Profile

It is a home appliances private limited company based in Kanpur, Uttar Pradesh, India, established in 2018.
2018 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Driota Pharma Private Limited

Driota Pharma Private Limited, a active private limited company, was established on 23 October 2018 in Kanpur, Uttar Pradesh, India. Engaging in specialized stores within the home appliances sector, it holds CIN: U52311UP2018PTC109525. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ravikash Srivastava (Director), Ramavakil (Director). Past directors included Vijay Mishra. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 117/H-2/186A Pandu Nagar, Kanpur, Uttar Pradesh, 208005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52311UP2018PTC109525

  • Registration Number

    109525

  • Incorporation Date

    23 October 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -42.96%
  • Profit Growth **** -36.09%
  • Ebitda **** 264.86%
  • Net Worth 19.48%
  • Total Assets -36.48%
Company report

Driota Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Driota Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Driota Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravikash Srivastava Director 23 Oct 2018 Current
Ramavakil Director 23 Apr 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Apr 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Driota Pharma.

Driota Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 42.96% decrease. The company also saw a substantial fall in profitability, with a 36.09% decrease in profit. The company's net worth Soared by an impressive increase of 19.48%.

Driota Pharma revenue growth over time
Driota Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -42.96%
*******
*******
*******
*******
Revenue from Operations
*******
 -44.08%
*******
*******
*******
*******
Total Assets
*******
 -36.48%
*******
*******
*******
*******
Profit or Loss
*******
 -36.09%
*******
*******
*******
*******
Net Worth
*******
 19.48%
*******
*******
*******
*******
EBITDA
*******
 264.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Driota Pharma?

Unlock access to Driota Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Driota Pharma?

Unlock and access historical data on people associated with Driota Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Driota Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Driota Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Driota Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Driota Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Driota Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Director Appointment

    The activity Ramavakil was appointed as a Director was appointed as a Director on 23 Apr 2022 & has been associated with this company since 3 years 11 months . was completed.

  • Director Appointment

    Ravikash Srivastava was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Driota Pharma Private Limited was registered on 23 Oct 2018 with Roc Kanpur & aged 7 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Driota Pharma Private Limited?

The CIN of Driota Pharma Private Limited is U52311UP2018PTC109525.

Where is Driota Pharma Private Limited headquartered?

Driota Pharma Private Limited is headquartered at 117/H-2/186A Pandu Nagar, Kanpur, Uttar Pradesh, 208005.

When was Driota Pharma Private Limited incorporated?

Driota Pharma Private Limited was incorporated on 23 October 2018.

Who are the current directors of Driota Pharma Private Limited?

The current directors of Driota Pharma Private Limited are

What is the primary industry of Driota Pharma Private Limited?

The primary industry of Driota Pharma Private Limited is Home Appliances.

Is Driota Pharma Private Limited a listed company?

Driota Pharma Private Limited is unlisted.

What is the capital structure of Driota Pharma Private Limited?

The authorized capital of Driota Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available